Patents by Inventor Randall E. Morris

Randall E. Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapies that improve graft survival
    Publication number: 20030161827
    Abstract: The invention provides methods for downmodulating the immune response in a subject undergoing transplantation comprising administering to the subject at least one antibody that recognizes a B7 antigen according to specific treatment protocols.
    Type: Application
    Filed: September 5, 2002
    Publication date: August 28, 2003
    Inventors: Abbie Cheryl Celnicker, Gary S. Gray, Stuart Friedrich, Allan Kirk, Garvin Warner, Bernard Hausen, Randall E. Morris
  • Method for inhibiting allograft rejection by the administration of 6-azauridine or its triacetate derivative
    Patent number: 5571800
    Abstract: A method for suppressing the rejection of an allograft comprising administering azaribine at a time when the recipient of the allograft begins to mount a reject reaction against the allograft.
    Type: Grant
    Filed: February 14, 1994
    Date of Patent: November 5, 1996
    Assignee: Azura, Inc.
    Inventors: Randall E. Morris, Robert I. Fox, William Drell
  • Method of treating hyperproliferative vascular disease
    Patent number: 5563146
    Abstract: This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of rapamycin alone or in combination with mycophenolic acid.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: October 8, 1996
    Assignee: American Home Products Corporation
    Inventors: Randall E. Morris, Clare R. Gregory
  • Method of treating hyperproliferative vascular disease
    Patent number: 5519042
    Abstract: A method of preventing or treating hyperproliferative vascular disease in a mammal consists of administering to a mammal an effective amount of carboxyamide compounds.
    Type: Grant
    Filed: January 13, 1994
    Date of Patent: May 21, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Randall E. Morris, Robert R. Bartlett
  • Method of treating restenosis with rapamycin
    Patent number: 5516781
    Abstract: This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an antiproliferative effective amount of rapamycin alone or in combination with mycophenolic acid.
    Type: Grant
    Filed: May 12, 1994
    Date of Patent: May 14, 1996
    Assignee: American Home Products Corporation
    Inventors: Randall E. Morris, Clare R. Gregory
  • Method of treating hyperproliferative vascular disease
    Patent number: 5283257
    Abstract: This invention provides a method of preventing or treating hyperproliferative vascular disease in a mammal by administering an amount of mycophenolic acid effective to inhibit intimal thickening.
    Type: Grant
    Filed: July 10, 1992
    Date of Patent: February 1, 1994
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Clare R. Gregory, Randall E. Morris
  • Concanavalin A dimers as therapeutic agents
    Patent number: 4889842
    Abstract: Homogeneous dimeric forms of concanavalin A, including the dimer form of native concanavalin A and dimeric derivatives of concanavalin A, are effective immunoregulatory agents with a good balance of high activity and low toxicity. Immunoregulatory pharmaceutical materials composed of one or a mixture of such isolated dimeric materials are disclosed as are methods of inducing immunoregulation in mammals by administering to such mammals an effective immunoregulatory amount of such pharmaceutical materials.
    Type: Grant
    Filed: March 3, 1987
    Date of Patent: December 26, 1989
    Inventor: Randall E. Morris